Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19
Clinical trial NCT05675072 · UNKNOWN
Trial details
- NCT number
- NCT05675072
- Sponsor
- Frontier Biotechnologies Inc.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-04
- Primary completion
- 2023-09-01
- Enrollment
- 1336
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.